Becton, Dickinson and Co. | BDX - Market Capitalization


Becton, Dickinson and Co. reported $52.24B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
Agilent USD 39.08B 6.43B Jun/2026
Align Technology USD 12.08B 198M Jun/2026
AngioDynamics USD 511M 94M Sep/2025
Baxter International USD 11.01B 2.34B Jun/2026
Becton, Dickinson and Co. USD 41.7B 3.07B Jun/2026
Bio-Rad Laboratories USD 7.87B 390M Jun/2026
Boston Scientific USD 63.44B 29.82B Jun/2026
Cooper Companies USD 12.67B 1.44B Sep/2026
Danaher USD 138.86B 10.4B Jun/2026
Dentsply International USD 2.13B 191M Jun/2026
Dexcom USD 25.99B 1.82B Jun/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Globus Medical USD 10.73B 963M Jun/2026
Insulet USD 10.55B 3.99B Jun/2026
Integra LifeSciences USD 1.4B 664M Jun/2026
Intuitive Surgical USD 140.84B 22.89B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Medtronic USD 113.81B 4.51B Sep/2026
Stryker USD 120.7B 5.15B Jun/2026
Tandem Diabetes Care USD 1.03B 276M Jun/2026
Teleflex USD 5.61B 317M Jun/2026
Terumo JPY 3.31T 186.55B Jun/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
WK Kellogg Co USD 13.36B 2.04B Jun/2026
Zimmer Biomet Holdings USD 16.66B 845M Jun/2026